ECTORS, the European Cell Therapy and Organ Regeneration Section of ESOT, would like to announce a call for nominations for two new Board members. The new ECTORS Board Members will hold office for four years (2023-2027), starting at the ESOT Congress, September 2023. All ESOT/ECTORS affiliates active in the field of regenerative medicine or cell
Category: Organ regeneration
Hope vs hype
“What has been achieved in tissue engineering and regenerative medicine?” Tissue engineering and organ regeneration expert, Ekaterine Berishvili, discusses the progress, opportunities and challenges of regeneration and repair in organ transplantation.
FINAL PROGRAMME: 12th EPITA Symposium & 41st AIDPIT Workshop
Update on our 12th EPITA Symposium & 41st AIDPIT Workshop! You can now find the final programme including Oral Presentations here. #ESOT_EPITA
ESOT manual for clinical practice guidelines
This handbook formalises the processes associated with the preparation of ESOT CPGs, including selecting topics for new guidelines, writing and reviewing approval, dissemination, and updating. Moreover, it defines the governance of the process.
ECTORS call for nominations
ECTORS, the European Cell Therapy and Organ Regeneration Section of ESOT, would like to announce a call for nominations for two new Board members. ESOT/ECTORS members active in the field of regenerative medicine or cell therapy are eligible to submit their applications for the positions. The Board reserves the right to shortlist candidates on the
ECTORS Call for nominations
We would like to announce a call for nominations for two new Board members. ESOT/ECTORS members active in the field of regenerative medicine or cell therapy are eligible to submit their application for the positions. The Board reserves the right to shortlist candidates on the basis of their specialty. If you wish to apply, please
Cell Therapy and Organ Regeneration in Transplantation
REGISTER TODAY – CLICK HERE Registration to 2nd ECTORS Meeting is complimentary, but only registered participants will have access. The Programme is available here
ESOT Congress 2021: Abstract Submission Deadline EXTENDED
The abstract submission deadline for #ESOTcongress has been EXTENDED until Thursday 25th February at 23:59 CET.
The COVID-19 Vaccine Studies
Transplant patients are exceptionally vulnerable to all infections, especially COVID-19, due to immunosuppression and other co-morbidities. There is a clear need for these patients to receive the best available protection against COVID-19 and we strongly believe that they should be considered as a priority group for vaccination across Europe. Furthermore, our patients and the broader
Transplant International is looking for its publishing partner
ESOT is seeking a publisher for its flagship scientific journal, Transplant International, to discuss the transition to an open access journal.